SOUTH SAN FRANCISCO, Calif., July 31, 2012 (GLOBE NEWSWIRE) -- Theravance, Inc. (Nasdaq:THRX) reported today its financial results for the quarter ended June 30, 2012. Revenue for the second quarter of 2012 was $1.4 million. Net loss for the second quarter of 2012 was $37.1 million or $0.42 per share. Cash, cash equivalents, and marketable securities totaled $378.7 million as of June 30, 2012.
